OS	Overall survival
PFS	Progression-free survival
HR	Hazard ratio
CI	Confidence interval
Pembro	Pembrolizumab
Nivo/ipi	Nivolumab plus ipilimumab
MM	Malignant melanoma
ECOG	Eastern Cooperative Oncology Group
U/L	Units/liter
LHD	Lactate dehydrogenase
CRP	C-reactive protein
PD-L1	Programmed death ligand 1
EDTA	Ethylenediaminetetraacetic acid
IFN	Interferon
IL	Interleukin
CXCL10	C-X-C motif chemokine ligand 10
CCL20	Chemokine (C-C-motif) ligand 20
TNF	Tumor Necrosis factor
MCP	Monocyte Chemoattractant Protein 1
PD-1	Programmed cell death protein 1
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4
UMAP	Uniform Manifold Approximation and Projection
CD8	Cluster of differentiation 8
TGF-β	Transforming growth factor β
PET/CT	Position emission tomography/computed tomography
MRI	Magnetic resonance imaging
NSCLC	Non-small cell lung cancer